Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors
Oncotarget · 2024
DOI: 10.18632/oncotarget.28650 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncotarget, 2024. Verfasst von Joshua J Lingo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, B7-H1 Antigen, Cyclin-Dependent Kinase 4, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.
- Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.
- Medical Scientist Training Program, University of Iowa, Iowa City, IA 52242, USA.
- Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, IA 52242, USA.
- Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Lingo, J. J., Voigt, E., & Quelle, D. E. (2024). Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors. Oncotarget. https://doi.org/10.18632/oncotarget.28650
Vancouver
Lingo JJ, Voigt E, Quelle DE. Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors. Oncotarget. 2024. doi:10.18632/oncotarget.28650
BibTeX
@article{Lingo2024,
author = {Lingo, Joshua J and Voigt, Ellen and Quelle, Dawn E},
title = {Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors},
journal = {Oncotarget},
year = {2024},
doi = {10.18632/oncotarget.28650}
}
EUVIMED